olprinone has been researched along with Brain Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujikawa, K; Inoue, K; Kakihana, Y; Kanmura, Y; Matsunaga, A; Miyata, A; Nagayama, T; Okayama, N; Takeyama, M | 1 |
| Cuzzocrea, S; Esposito, E; Genovese, T; Mazzon, E; Paterniti, I | 1 |
2 other study(ies) available for olprinone and Brain Ischemia
| Article | Year |
|---|---|
The effects of the phosphodiesterase inhibitor olprinone on global cerebral ischemia.
Topics: Animals; Blotting, Western; Brain Ischemia; CA1 Region, Hippocampal; Cell Hypoxia; Cell Survival; Cells, Cultured; Cerebrovascular Circulation; Cyclic AMP Response Element-Binding Protein; Cyclic Nucleotide Phosphodiesterases, Type 3; Disease Models, Animal; Dose-Response Relationship, Drug; Glucose; Imidazoles; Male; Neurons; Neuroprotective Agents; Phosphodiesterase 3 Inhibitors; Phosphodiesterase Inhibitors; Phosphorylation; Pyridones; Rats; Rats, Wistar; Time Factors | 2010 |
Neuroprotective effects of olprinone after cerebral ischemia/reperfusion injury in rats.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Behavior, Animal; Brain; Brain Ischemia; Cerebral Cortex; Corpus Striatum; Cyclic Nucleotide Phosphodiesterases, Type 3; Imidazoles; Immunohistochemistry; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Phosphodiesterase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Pyridones; Rats; Rats, Wistar; Reactive Nitrogen Species; Reactive Oxygen Species; Reperfusion Injury | 2011 |